ROYAL BANK OF CANADA - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 3 filers reported holding TG THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$353,000
-53.9%
42,201
+36.7%
0.00%
Q2 2023$766,000
-20.0%
30,862
-51.5%
0.00%
Q1 2023$957,000
+20.5%
63,654
-5.2%
0.00%
Q4 2022$794,000
+409.0%
67,130
+154.6%
0.00%
Q3 2022$156,000
-29.4%
26,372
-49.5%
0.00%
Q2 2022$221,000
-77.1%
52,220
-48.5%
0.00%
Q1 2022$964,000
-31.1%
101,420
+37.7%
0.00%
Q4 2021$1,399,000
-15.6%
73,654
+47.8%
0.00%
Q3 2021$1,657,000
-36.6%
49,831
-26.0%
0.00%
-100.0%
Q2 2021$2,612,000
-41.9%
67,328
-27.8%
0.00%0.0%
Q1 2021$4,493,000
+394.3%
93,192
+433.7%
0.00%
Q4 2020$909,000
+309.5%
17,463
+111.2%
0.00%
Q3 2020$222,000
+57.4%
8,268
+14.9%
0.00%
Q2 2020$141,000
+182.0%
7,197
+43.1%
0.00%
Q1 2020$50,000
-56.1%
5,028
-50.8%
0.00%
Q4 2019$114,000
+72.7%
10,222
-12.9%
0.00%
Q3 2019$66,000
-39.4%
11,735
-7.5%
0.00%
Q2 2019$109,000
+16.0%
12,686
+8.8%
0.00%
Q1 2019$94,000
+95.8%
11,6550.0%0.00%
Q4 2018$48,000
-7.7%
11,655
+26.9%
0.00%
Q3 2018$52,000
-72.2%
9,185
-35.3%
0.00%
Q2 2018$187,000
+76.4%
14,198
+91.0%
0.00%
Q1 2018$106,000
-7.8%
7,434
-47.0%
0.00%
Q4 2017$115,000
+82.5%
14,027
+162.6%
0.00%
Q3 2017$63,000
+2000.0%
5,341
+1800.7%
0.00%
Q2 2017$3,000
-88.5%
281
-87.9%
0.00%
Q1 2017$26,000
+333.3%
2,325
+62.7%
0.00%
Q4 2016$6,000
+500.0%
1,429
+1561.6%
0.00%
Q3 2016$1,0000.0%86
-52.0%
0.00%
Q2 2016$1,000179
+795.0%
0.00%
Q1 2016$020
+17.6%
0.00%
Q4 2015$0
-100.0%
17
-98.6%
0.00%
Q3 2015$12,000
+300.0%
1,241
+520.5%
0.00%
Q2 2015$3,0000.0%2000.0%0.00%
Q1 2015$3,000
+50.0%
200
-37.5%
0.00%
Q3 2013$2,0003200.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
BRIDGER MANAGEMENT, LLC 1,647,000$6,423,0000.45%
DAFNA Capital Management LLC 75,000$293,0000.30%
Baker Brothers Advisors 2,199,656$8,579,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 71,105$277,0000.05%
SMITH ASSET MANAGEMENT GROUP LP 196,684$767,0000.03%
SABBY MANAGEMENT, LLC 66,000$257,0000.02%
THOMPSON DAVIS & CO., INC. 1,000$4,0000.01%
COLUMBUS CIRCLE INVESTORS 161,919$631,0000.00%
JENNISON ASSOCIATES LLC 455,271$1,776,0000.00%
BlackRock Fund Advisors 448,445$1,749,0000.00%
View complete list of TG THERAPEUTICS INC shareholders